Purple Biotech Ltd
PPBT2.330USD
-0.290-11.07%
종가 07/25, 16:00（ET）시세는 15분 지연됩니다
1.24B시가총액
손실P/E TTM
자세한 내용은 Purple Biotech Ltd 회사
Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
회사 정보
종목 코드 PPBT
회사 이름Purple Biotech Ltd
상장일Sep 03, 1978
설립일1968
CEOMr. Gil Efron, CPA
직원 수9
유형Ordinary Share
회계 연도 종료Sep 03
주소4 Oppenheimer St.
도시REHOVOT
증권 거래소Tel Aviv Stock Exchange
국가Israel
우편 번호7670104
전화97239333121
웹사이트https://purple-biotech.com/
종목 코드 PPBT
상장일Sep 03, 1978
설립일1968
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
Dr. Bertrand Liang
Dr. Bertrand Liang
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Arie Weber
Mr. Arie Weber
Independent Director
Independent Director
--
--
Ms. Revital Stern-Raff
Ms. Revital Stern-Raff
Independent Director
Independent Director
--
--
Dr. Hadas Reuveni
Dr. Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Steven Steinberg
Mr. Steven Steinberg
Independent Director
Independent Director
--
--
Mr. Avraham Ben-Tzvi
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
--
--
Mr. Yisrael Gewirtz
Mr. Yisrael Gewirtz
Internal Auditor
Internal Auditor
--
--
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Chairman of the Board
--
--
Mr. Gil Efron, CPA
Mr. Gil Efron, CPA
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Itzhak Israel
Mr. Itzhak Israel
Director
Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Tue, Jul 15
마지막 업데이트: Tue, Jul 15
주주
주주 유형
주주
주주
비율
UBS Financial Services, Inc.
0.81%
Kingswood Wealth Advisors, LLC
0.59%
BNP Paribas Securities Corp. North America
0.19%
Morgan Stanley & Co. LLC
0.16%
GAMMA Investing LLC
0.16%
Other
98.10%
주주
주주
비율
UBS Financial Services, Inc.
0.81%
Kingswood Wealth Advisors, LLC
0.59%
BNP Paribas Securities Corp. North America
0.19%
Morgan Stanley & Co. LLC
0.16%
GAMMA Investing LLC
0.16%
Other
98.10%
주주 유형
주주
비율
Investment Advisor
1.44%
Research Firm
0.35%
Investment Advisor/Hedge Fund
0.16%
Other
98.06%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
36
50.71K
1.79%
-206.29K
2025Q1
39
103.31K
6.70%
-153.87K
2024Q4
41
133.07K
5.02%
-58.34K
2024Q3
39
222.98K
11.78%
+111.64K
2024Q2
39
147.98K
8.71%
+1.90K
2024Q1
40
184.47K
11.90%
+40.99K
2023Q4
40
174.27K
11.63%
+106.33K
2023Q3
38
64.91K
3.14%
-5.47K
2023Q2
37
13.88K
1.30%
-49.49K
2023Q1
37
6.26K
0.60%
-57.26K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
UBS Financial Services, Inc.
23.02K
0.81%
+12.24K
+113.53%
Mar 31, 2025
Kingswood Wealth Advisors, LLC
16.80K
0.59%
-16.80K
-50.00%
Mar 31, 2025
BNP Paribas Securities Corp. North America
5.38K
0.19%
--
--
Mar 31, 2025
Morgan Stanley & Co. LLC
4.46K
0.16%
-600.00
-11.85%
Mar 31, 2025
Rhumbline Advisers Ltd. Partnership
805.00
0.03%
+200.00
+33.06%
Mar 31, 2025
RBC Dominion Securities, Inc.
107.00
0%
--
--
Mar 31, 2025
Northwestern Mutual Capital, LLC
85.00
0%
+85.00
--
Mar 31, 2025
SBI Securities Co., Ltd.
20.00
0%
-170.00
-89.47%
Mar 31, 2025
Global Retirement Partners, LLC
16.00
0%
--
--
Dec 31, 2024
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
날짜
유형
비율
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Sep 06, 2024
Merger
20<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
Aug 13, 2020
Merger
10<1
